Tanzania TMDA Online Submission via Trader’s Portal and Sample Requirements

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Tanzania has no paper submission channel. All applications (new applications, variations, renewals) must be submitted online through the TMDA Trader’s Portal. An application consists of three components: documents in electronic form + samples + fees. Removing any one of the three components leaves the application incomplete, and the portal workflow will not let the file advance.

Samples are a hard gate: Part I §4 opens with the statement “Sample submission is a requirement for marketing authorization”, and adds that “Applications that are not accompanied by samples shall not proceed with the assessment process”. The sample requirement is therefore not a courtesy; it is a condition precedent to the entire assessment.

The sample quantity rules (Part I §4) are as follows:

Device typeSample requirement
All single-use devices (new applications and re-registration)2 commercial packages; additional samples may be requested during assessment
Reusable devices of small volume2 samples (same as single-use devices)
Devices for use by the untrained layman2 samples
Large-scale devices, components of hospital infrastructure, cardiac implantsLabel artwork plus scaled images from different angles (360° views) may be submitted in place of physical samples

2. Legal basis

InstrumentNumberPublication dateProvisions
Compendium of Guidelines for Marketing Authorization of Medical Devices, Diagnostics and Laboratory EquipmentNo gazette number (TMDA guidance document)June 2024Part I §3.4.1, §3.4.3, §4
The Tanzania Food, Drugs and Cosmetics (Control of Medical Devices) Regulations, 2015GN. No. 31531 July 2015Section 7(2)(b) (samples and artwork), Section 11 (additional information may be requested), Section 12(2) (additional samples may be requested)
Procedure for Marketing Authorization (TMDA website)No gazette number (TMDA guidance document)No publication date stated (current TMDA version)Step 3: Create a trader portal account

3. Expert insights

Insight 1: Samples must be submitted after payment, and without submission the assessment freezes.

Part I §3.4.1: an application consists of electronic documents, samples and fees. §4: “all samples shall be submitted after payment of applications”. Payment is therefore the first gate and samples the second. If either gate is not passed, the application does not enter assessment. GRZAN’s experience is to schedule international sample shipping (including customs clearance) as a separate workstream in the project plan, never in parallel with document preparation as if interchangeable; the two activities have different failure modes and different recovery times.

Insight 2: Five items of information must be ready before submission, or the portal entry cannot be completed.

Part I §3.4.1 requires the applicant to have, before lodging the dossier: a) the device class; b) the intended purpose; c) the GMDN code and term; d) the conformity assessment certificate; and e) the Declaration of Conformity. The GMDN code and term are mandatory fields and must be retrieved and confirmed in the GMDN system in advance. Discovering at submission time that the GMDN term does not exist for the product forces a re-mapping exercise and delays the entire application.

Insight 3: Fees are non-refundable across the board, and bank charges are for the applicant’s account.

Part I §3.4.3 states expressly “All fees are non-refundable” and requires payment through the control number generated on the TMDA invoice. Where payment is made by bank transfer, all bank charges are borne by the applicant, and a payment advice note must be sent separately stating the applicant’s name, the names of the devices paid for and the amount; where a device is already registered, the registration number must be quoted as well. Omitting this step leaves the payment unreconciled against the application and stalls the file in screening.

Insight 4: The 1–2 working-day invoice at screening is the only step with an explicit number on the receiving side.

Part I §3.4.2: upon receipt of an application, TMDA first screens it for completeness and issues the payment invoice within 1–2 working days. Incomplete applications are queried and returned for correction; products wrongly applied for under notification are rejected outright and returned to the applicant (“Applications for incorrect products applied for notifications will be rejected and returned to the applicant”). The screening step is short but decisive, and it is where route-selection errors surface first.

Insight 5: Sections 7(2)(b) and 12(2) of GN 315 give TMDA two separate powers to demand samples.

Section 7(2)(b) requires samples or artwork to accompany the application at submission; Section 12(2) further provides that in examining an application, TMDA may require the applicant to submit additional information or device samples. Requests for additional samples during assessment are therefore the norm, not the exception, and the project budget should reserve a second sample shipment with its own shipping and clearance time.

4. Practical recommendations

  1. List sample shipping on the critical path. International transport of 2 commercial packages plus clearance typically takes weeks, and Section 7(2)(b) of GN 315 requires the samples to be in place at submission.
  2. Confirm the GMDN code and term early; these are mandatory portal fields, not nice-to-have metadata.
  3. Send the advice note after every payment; for registered devices quote the registration number, otherwise reconciliation fails.
  4. When large equipment uses the artwork + 360° image route, the images must cover all angles with scale indicated, consistent with the Part IV §3.2.1(b) requirement for notification applications that all faces be clearly visible.
  5. Reserve budget for a second sample shipment (Section 12(2)).

5. Verification checklist

  • □ An account has been created on the TMDA Trader’s Portal and the submission completed online.
  • □ The five advance items are ready (class, intended purpose, GMDN, conformity assessment certificate, Declaration of Conformity).
  • □ Sample quantities match the rules: 2 for single-use / small reusable / layman-use devices; artwork + 360° images for large devices.
  • □ Samples are submitted after payment.
  • □ The advice note has been sent after payment, quoting the registration number where the device is registered.
  • □ Time and budget for additional samples during assessment have been reserved.

Regulatory information verified as of 29 October 2026. All provisions cited in this article were checked against the texts officially published by TMDA (June 2024 Compendium Part I §3.4.1–§3.4.3 and §4; GN. No. 315 Sections 7 and 12); the content is re-reviewed whenever the regulations are updated.

  • Local resources in Tanzania: GRZAN can coordinate licensed local responsible persons (LRP) and distributor resources covering online submission, sample delivery, quality audit support and port clearance.
  • Service capabilities: classification determination, route selection between registration and notification, technical documentation (CSDT/STED) preparation and localization, GMDN coding and grouping strategy, clinical evidence organization, software and AI device submissions, change management, vigilance and PMS reporting, annual retention fees and renewal management.
  • Contact: hito.lin@grzan.cn; website www.grzan.cn.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail